What Is the Nipah Virus and Why Is It More Deadly Than COVID-19? A Virus Expert Explains.
Officials in India are racing to contain a virus outbreak that has claimed the life of a 12-year-old boy and is deadlier than COVID-19 — the Nipah virus.
UF Health Researcher, Collaborators Discover Compounds That Might Boost Stroke Recovery
When a patient suffers a stroke, oxygen-starved brain cells begin dying within minutes. In these crucial moments, the brain produces a vital catalyst to protect itself and aid in recovery. That catalyst — an enzyme known as neurolysin — activates a cascade of chemical messengers that reduce cell damage, swelling and inflammation in the brain. Now, a University of Florida Health researcher and his collaborators at Texas Tech University and other universities have discovered two compounds that appear to make the brain-protecting enzyme even more effective.
HIV Drug Shows Potential To Combat Genetic Form of Dystonia in Preclinical Study
A new UF study found that an FDA-approved medication to treat HIV restored multiple brain abnormalities in a mouse model of a genetic form of dystonia.
AGTC Is Excited To Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber As Their New Chief Financial Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, announced Jonathan I. Lieber as their new Chief Financial Officer.
TearClear Files Investigational New Drug (IND) Application To Begin Its Clinical Trial for TC-002 Latanoprost Ophthalmic Solution, 0.005%
UF startup and UF Innovate | Sid Martin Biotech company TearClear, a late clinical-stage ophthalmic pharmaceutical company, has filed an Investigational New Drug (IND) application to conduct a registrational study for its lead glaucoma candidate, TC-002 latanoprost ophthalmic solution, 0.005%.
Does My Child Have Duchenne Muscular Dystrophy? Take the Quiz.
Duchenne muscular dystrophy — sometimes referred to simply as Duchenne — is a genetic disorder that causes progressive muscle loss and weakness. It occurs as a result of gene mutations involved in the production of a protein called dystrophin, according to the Muscular Dystrophy Association (MDA).
AGROVIEW Company Joins NVIDIA Inception
UF startup and UF Innovate | The Hub resident Agriculture Intelligence, the parent company of Agroview, announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in AI and data sciences.
The Future Is Now – UF Design, Construction and Planning Department Is Developing AI Curriculum for Faculty and Students
On a hot, muggy morning in July 2020, University of Florida President Kent Fuchs announced an astonishing $70 million public-private partnership between UF and NVIDIA, thus making artificial intelligence (AI) the centerpiece of a major, long-term initiative combining world-class research infrastructure, cutting-edge analysis and a revolutionary approach to curriculum.
UF Scientists Use AI To Try to More Accurately Predict Citrus Yield
University of Florida researchers are using artificial intelligence to help citrus growers better forecast their seasonal production. So far, they’ve found in a preliminary study that their technology predicts yields with 98 percent accuracy.
UF Research Provides Insight to Equine Metabolic Syndrome
Equine metabolic syndrome, a common equine condition, often proves difficult for veterinarians to diagnose and treat. Recent UF/IFAS research into genetic factors contributing to the disease provides guidance on how to manage horses so owners can prevent the disease.
